Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Apr 1;139(4):969-82.
doi: 10.1084/jem.139.4.969.

Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors

Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors

G Möller. J Exp Med. .

Abstract

By the use of a rosette method allowing the detection at the cellular level of lymphocytes simultaneously binding Fc- and C'3-sensitized red cells it was found that about 70% of the rosette-forming cells from spleens of nude and normal mice possessed receptors for both Fc and C'3, whereas 30% only had Fc receptors. Very few, if any, lymphocytes possessed only C'3 receptors. The B-cell mitogens, purified-protein derivative of tuberculin (PPD), lipopolysaccharide from Escherichia coli (LPS), and pneumococcal polysaccharide type SIII (SIII), induced marked changes of these receptor-bearing lymphocytes. PPD caused a rapid loss of cells capable of binding C'3 and a concomitant increase of only Fc-binding cells, which was detected after only 24 h. LPS and SIII induced analogous changes, but they were not detected until 48 h and were not complete until after 72 h. It is suggested that immature lymphocytes possess both Fc and C'3 receptors and lose the latter receptor upon differentiation induced by B-cell mitogens PPD. and LPS would affect different populations of B cells, PPD-activating cells that have already reached a higher differentiation stage, whereas LPS and SIII would activate more immature B cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Immunol. 1973 May;3(5):299-306 - PubMed
    1. Adv Immunol. 1969;11:117-93 - PubMed
    1. Nature. 1970 Sep 19;227(5264):1246-8 - PubMed
    1. J Exp Med. 1970 Oct 1;132(4):702-20 - PubMed
    1. Eur J Immunol. 1973 Sep;3(9):531-7 - PubMed

MeSH terms